Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Classement en actions #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Prix de l'action
$0.2488447
Dernière synchronisation: 2024-10-01
Capitalisation boursière
$2.01M
Changement (1 jour)
-1.88%
Changement (1 an)
0.00%
Pays
IN
Échange Ortin Laboratories Limited (ORTINLAB)

Catégorie

Bénéfices pour Ortin Laboratories Limited (ORTINLAB)
Bénéfices en Jun 2024 TTM : $-862.73K
Selon les derniers rapports financiers de Ortin Laboratories Limited, les bénéfices actuels de l'entreprise sont de $-862.73K. En 2023, l'entreprise a réalisé un bénéfice de $-10.20K, une augmentation par rapport à celui de 2022 qui était de $-69.81K. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Ortin Laboratories Limited de 2008 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $-862.73K 1.68%
2024 $-848.51K 8,221.19%
2023 $-10.20K -85.39%
2022 $-69.81K -474.55%
2021 $18.64K -80.46%
2020 $95.37K -63.97%
2019 $264.69K 153.29%
2018 $104.50K -33.59%
2017 $157.35K -25.29%
2016 $210.63K -1.43%
2015 $213.68K -23.89%
2014 $280.75K -17.87%
2013 $341.84K -33.53%
2012 $514.27K 8.07%
2011 $475.88K 64.44%
2010 $289.39K 48.21%
2009 $195.26K -47.62%
2008 $372.80K 0.00%
Bénéfices des entreprises similaires ou concurrentes